blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0993452

EP0993452 - ANGIOGENESIS INHIBITING 5-SUBSTITUTED-1,2,4-THIADIAZOLYL DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.07.2008
Database last updated on 12.07.2024
Most recent event   Tooltip01.01.2010Lapse of the patent in a contracting state
New state(s): CY
published on 03.02.2010  [2010/05]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2000/16]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / STOKBROEKX, Raymond, Antoine
Rode Kruisstraat 17
B-2340 Beerse / BE
02 / CEUSTERS, Marc, André
Bredestraat 18
B-3293 Diest / BE
03 / VAN DER AA, Marcel, Jozef, Maria
Patersstraat 155 bus 1
B-2300 Turnhout / BE
04 / LUYCKX, Marcel, Gerebernus, Maria
Eksterstraat 24
B-2440 Geel / BE
05 / WILLEMS, Marc
Merellaan 46
B-2350 Vosselaar / BE
06 / TUMAN, Robert, W.
103 Homestead Court
Chalfont, PA 18914 / US
[2000/16]
Representative(s)Daelemans, Frank F.R., et al
Janssen Pharmaceutica N.V., Patent Department, Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2000/16]Daelemans, Frank, et al
Janssen Pharmaceutica N.V., Patent Department, Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date98937560.522.06.1998
[2000/16]
WO1998EP04022
Priority number, dateEP1997020193124.06.1997         Original published format: EP 97201931
US19970053003P10.07.1997         Original published format: US 53003 P
[2000/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9858919
Date:30.12.1998
Language:EN
[1998/52]
Type: A1 Application with search report 
No.:EP0993452
Date:19.04.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.1998 takes the place of the publication of the European patent application.
[2000/16]
Type: B1 Patent specification 
No.:EP0993452
Date:05.09.2007
Language:EN
[2007/36]
Search report(s)International search report - published on:EP30.12.1998
ClassificationIPC:C07D285/08, C07D285/135, C07D417/04, A61K31/41, A61K31/495, C07D213/83, C07D241/28, C07D295/155
[2000/16]
CPC:
C07D285/135 (EP,KR,US); A61K31/433 (KR); A61K31/381 (KR);
A61P17/02 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP);
A61P9/00 (EP); C07D213/83 (EP,KR); C07D241/26 (EP,KR);
C07D241/28 (EP,US); C07D285/08 (EP,KR); C07D295/155 (EP,KR);
C07D417/04 (EP,KR); C07D417/12 (EP,KR) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/16]
Extension statesLT24.01.2000
LV24.01.2000
RO24.01.2000
SI24.01.2000
TitleGerman:ANGIOGENESE-HEMMENDE 5-SUBSTITUIERTE-1,2,4-THIADIAZOLYLDERIVATE[2000/16]
English:ANGIOGENESIS INHIBITING 5-SUBSTITUTED-1,2,4-THIADIAZOLYL DERIVATIVES[2000/16]
French:DERIVES DE 5-SUBSTITUES-1,2,4-THIADIAZOLYLE INHIBANT ANGIOGENESE[2000/16]
Entry into regional phase24.01.2000National basic fee paid 
24.01.2000Designation fee(s) paid 
24.01.2000Examination fee paid 
Examination procedure18.11.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.01.2000Examination requested  [2000/16]
28.04.2003Despatch of a communication from the examining division (Time limit: M04)
08.08.2003Reply to a communication from the examining division
24.10.2006Cancellation of oral proceeding that was planned for 10.11.2006
24.10.2006Minutes of oral proceedings despatched
27.10.2006Despatch of a communication from the examining division (Time limit: M01)
10.11.2006Date of oral proceedings (cancelled)
24.11.2006Reply to a communication from the examining division
07.02.2007Communication of intention to grant the patent
18.06.2007Fee for grant paid
18.06.2007Fee for publishing/printing paid
Opposition(s)06.06.2008No opposition filed within time limit [2008/33]
Fees paidRenewal fee
30.06.2000Renewal fee patent year 03
02.07.2001Renewal fee patent year 04
01.07.2002Renewal fee patent year 05
30.06.2003Renewal fee patent year 06
30.06.2004Renewal fee patent year 07
30.06.2005Renewal fee patent year 08
30.06.2006Renewal fee patent year 09
02.07.2007Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.09.2007
CY05.09.2007
DK05.09.2007
FI05.09.2007
GR06.12.2007
PT06.02.2008
[2010/05]
Former [2008/35]AT05.09.2007
DK05.09.2007
FI05.09.2007
GR06.12.2007
PT06.02.2008
Former [2008/26]AT05.09.2007
FI05.09.2007
GR06.12.2007
PT06.02.2008
Former [2008/21]AT05.09.2007
FI05.09.2007
GR06.12.2007
Former [2008/16]AT05.09.2007
FI05.09.2007
Cited inInternational search[A]US5104889  (KANAI KENICHI [JP], et al) [A] 1-12 * column W *;
 [PX]WO9726258  (JANSSEN PHARMACEUTICA NV [BE], et al) [PX] 1-12* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.